February 10, 2026

From the CEO of Proscia: Best in KLAS and Why It Matters

From the Proscia blog From Proscia’s early days, we’ve believed that pathology deserves great technology. As cancer cases grow, the pathologist workforce shrinks, and diagnostic complexity rises, the demands on pathology teams continue to intensify. The...

recent articles

PathAI IBD Explore™ panel will empower drug developers with improved inflammatory microenvironment spatial characterization from H&E, propelling a new phase of precision medicine in IBD  BOSTON — May 17, 2023 —PathAI, a global...

Clinically Utilized by Labs Throughout the World, the Paige Platform is the Only Digital Pathology Solution Built for AI Offering Flexibility, Scalability, and Customization NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end...

Are you tired of the time-consuming and expensive process of traditional microscopy? It's time to revolutionize your practice with Motic Digital Pathology. Digital Pathology has proven to be a cost-effective, highly accurate, and reliable...

Budapest Business Journal: Investments in pharma and medtech are badly needed in Europe to keep pace with overseas competitors and prevent a large-scale brain drain. Against this backdrop, it is even more pleasing that Hungary’s healthcare...

England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably. England’s first centre of its kind is set to make significant improvements in cancer...

FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...

OR

platinum partners

gold partners

Silver Partners

Media Partners